Cassava Sciences (SAVA)
(Delayed Data from NSDQ)
$22.30 USD
-0.04 (-0.18%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $22.22 -0.08 (-0.36%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SAVA 22.30 -0.04(-0.18%)
Will SAVA be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for SAVA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SAVA
Brian's Big Idea on Low Priced Stocks
Cassava (SAVA) Up on Progress With Alzheimers Disease Study
SAVA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Mesa Laboratories (MLAB) Outperforming Other Medical Stocks This Year?
Cassava Sciences (SAVA) to Report Q3 Earnings: What's in Store?
Cassava Sciences, Inc. (SAVA) Dips More Than Broader Markets: What You Should Know
Other News for SAVA
Largest borrow rate increases among liquid names
SAVA June 7th Options Begin Trading
Largest borrow rate increases among liquid names
Largest borrow rate increases among liquid names
Largest borrow rate increases among liquid names